PORTLAND, OR – Home Dialysis Plus, Ltd (HD+) announces a strategic partnership with StarFish Medical (Victoria, BC) to provide product development and system integration services for its home hemodialysis unit. The partnership will dramatically accelerate the development cycle and time to market for the system.
Intended to offer patients the option to experience nightly nocturnal treatment, the HD+ system is expected to meet the needs of patients and caregivers with a cost-effective treatment option that easily integrates into their daily lives.
“With an increasing focus on home healthcare as an affordable and efficient treatment option, HD+ expects to offer patients the ability to track and manage their treatment more effectively and with improved results,” says Michael Baker, CEO, HD+.
The HD+ system is intended to provide patients with a slower, gentler nocturnal dialysis treatment that will reduce their post-treatment recovery time. Utilizing patented MECS technology and HP inkjet technology, the system is also expected to provide a smaller, more intuitive and cost-contained option than current dialysis solutions.
“We are excited to partner with HD+,” says Scott Phillips, President, StarFish Medical. “This project is a perfect match for the comprehensive technology development, product design and system integration skills at StarFish. We are delighted to be able to contribute to the success of this important new company and their breakthrough technology.” HD+ is the fourth new StarFish client this year in the areas of nephrology and hematology.
About Home Dialysis Plus, Ltd.
Home Dialysis Plus, Ltd. (HD+) is focused on the advancement of home hemodialysis treatment for patients suffering from end-stage renal disease. Via the use of patented microtechnology-based energy and chemical systems (MECS) and licensed HP inkjet technology, the company aims to produce home treatment options that will offer improved health outcomes through ultra-patient-friendly, portable hemodialysis machines. More information is available at Home Dialysis Plus, Ltd.
About StarFish Medical
For more than ten years, StarFish has provided practical and innovative solutions in all aspects of medical device design and manufacturing, from product definition and technical engineering to formal product development and volume production in a quality environment. StarFish, an ISO 13485 certified company, provides practical turnkey to medical device companies all over North America. The company’s cross-functional team offers expertise in engineering physics, electronics, software, firmware, mechanical engineering, industrial design and manufacturing transfer. More information is available at StarFish Medical.
This news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of HD+ and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to statements of the plans, strategies and objectives of management for future operations; any statements concerning expected development, performance or market share relating to products and services; anticipated operational and financial results; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. HD+ assumes no obligation and does not intend to update these forward-looking statements.
Home Dialysis Plus, Ltd.